BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol-induced peripheral neuropathy in rats.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  2003-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0041-008X(03)00155-8PMID 12831778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo

  2008cited by this paper
• Potentiation of the antitumor activity of cisplatin in mice by 3-aminobenzamide and nicotinamide

  2004cited by this paper
• Nerve Conduction Velocity and Spinal Reflexes May Change in Rats After Fumonisin B_1 Exposure

  2002cited by this paper
• BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity.

  2002cited by this paper
• Protective effect of poly(ADP-ribose) polymerase inhibitors against cell damage induced by antiviral and anticancer drugs

  2000cited by this paper
• Inhibition of GSK-3 activity is sufficient to protect primary cerebellar granule neurons from apoptotic cell death.

  2000cited by this paper
• BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.

  2000cited by this paper
• Neuroprotective interactions in rats between paclitaxel and cisplatin.

  2000cited by this paper
• Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.

  1999cited by this paper
• The effects of taxol (paclitaxel) on chemiluminescence of neutrophils, macrophages and J.774.2 cell line.

  1998cited by this paper
• Discrimination between genotoxicity and cytotoxicity in the induction of DNA double-strand breaks in cells treated with etoposide, melphalan, cisplatin, potassium cyanide, Triton X-100, and gamma-irradiation.

  1998cited by this paper
• Physiological characterization of taxol‐induced large‐fiber sensory neuropathy in the rat

  1998cited by this paper
• Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.

  1998cited by this paper
• Enhancing and priming of macrophages for superoxide anion production by taxol.

  1998cited by this paper
• Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.

  1998cited by this paper
• Poly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells.

  1998cited by this paper
• Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat.

  1997cited by this paper
• Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.

  1997cited by this paper
• Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

  1997cited by this paper
• Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia

  1997cited by this paper
• Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin

  1997cited by this paper
• A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer.

  1997cited by this paper
• Reactive oxygen intermediate(s) (ROI): Common mediator(s) of poly(ADP‐ribose)polymerase (PARP) cleavage and apoptosis

  1996cited by this paper
• Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway.

  1996cited by this paper
• Taxol induces bcl-2 phosphorylation and death of prostate cancer cells.

  1996cited by this paper
• Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.

  1996cited by this paper
• Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

  1996cited by this paper
• Neuroprotectant drugs in cisplatin neurotoxicity.

  1996cited by this paper
• Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2 (*)

  1996cited by this paper
• Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy

  1995cited by this paper
• Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities.

  1995cited by this paper
• Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity.

  1995cited by this paper
• Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial.

  1995cited by this paper
• Low-dose glutathione administration in the prevention of cisplatin-induced peripheral neuropathy in rats.

  1994cited by this paper
• Cisplatin generates superoxide anion by interaction with DNA in a cell-free system.

  1994cited by this paper
• Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices.

  1993cited by this paper
• Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment.

  1993cited by this paper
• The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats.

  1993cited by this paper
• High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer.

  1993cited by this paper
• Putative neurotrophic factors in the protection of cisplatin-induced peripheral neuropathy in rats.

  1991cited by this paper
• Taxol produces a predominantly sensory neuropathy

  1989cited by this paper
• Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats.

  1988cited by this paper
• Cisplatin neuropathy. Risk factors, prognosis, and protection by WR‐2721

  1988cited by this paper
• Org.2766 protects from cisplatin-induced neurotoxicity in rats.

  1987cited by this paper
• Sensory and motor nerve conduction velocities and the latency of the H reflex during growth of the rat.

  1981cited by this paper
• Promotion of microtubule assembly in vitro by taxol

  1979cited by this paper
• Cisplatin-induced Apoptosis Proceeds by Caspase-3-dependent and -independent Pathways in Cisplatin-resistant and -sensitive Human Ovarian Cancer Cell Lines Proteolytic Degradation of Procaspase-3 Was Observed in Both the Cp70 and C30 Cells following Ic 50 Cisplatin Treatment, Whereas No Pro- Teolyze

  year unknowncited by this paper

• BGP-15 alleviates LPS-induced depression-like behavior by promoting mitophagy.

  2024cites this paper
• Understanding pathophysiology of GNE myopathy and current progress towards drug development

  2024cites this paper
• Potential small effector molecules restoring cellular defects due to sialic acid biosynthetic enzyme deficiency: Pathological relevance to GNE myopathy.

  2024cites this paper
• Altered Autophagic Flux in GNE mutant cells of Indian Origin: potential drug target for GNE Myopathy.

  2024cites this paper
• Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis.

  2023cites this paper
• Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies

  2023cites this paper
• Improved Survival and Retinal Function of Aging ZDF Rats in Long-Term, Uncontrolled Diabetes by BGP-15 Treatment

  2021cites this paper
• Nicotinic Amidoxime Derivate BGP-15, Topical Dosage Formulation and Anti-Inflammatory Effect

  2021cites this paper
• Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options

  2020cites this paper
• Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone

  2020cites this paper
• A novel surfactant 2-(benzylthio)-acetohydroxamic acid: Synthesis, flotation performance and adsorption mechanism to cassiterite, calcite and quartz

  2020cites this paper
• Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome

  2020influential citation
• A Comparative Study between the Effect of Nerve Growth Factor and All-Trans Retinoic Acid versus their combined use on Taxol Induced Peripheral Neuropathy in Adult Male Albino Rat

  2019cites this paper
• Heat-Shock Proteins in Neuroinflammation

  2019cites this paper
• Co-treatment With BGP-15 Exacerbates 5-Fluorouracil-Induced Gastrointestinal Dysfunction

  2019cites this paper
• Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents.

  2019cites this paper
• Activation of mitochondrial fusion provides a new treatment for mitochondria‐related diseases

  2018cites this paper
• Oxaliplatin‐induced enteric neuronal loss and intestinal dysfunction is prevented by co‐treatment with BGP‐15

  2018cites this paper
• PARP inhibition in platinum‐based chemotherapy: Chemopotentiation and neuroprotection

  2018cites this paper
• 1 INFLUENCING AND INVESTIGATING INSULIN RESISTANCE BY A MOLECULE WITH A NEW MODE OF ACTION

  2017cites this paper
• BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species

  2017cites this paper
• Chemotherapy-Induced Gastrointestinal Dysfunction and Enteric Neuropathy

  2017influential citation
• 12 Novel Therapeutic Targets in Soft Tissue Sarcomas

  2017cites this paper
• BGP-15 prevents the death of neurons in a mouse model of familial dysautonomia

  2017cites this paper
• Poly(adenosine diphosphate-ribose) polymerase as therapeutic target: lessons learned from its inhibitors

  2017cites this paper
• Progress in Lipid Research

  2015cites this paper
• Curcumin Ameliorates Functional and Structural Abnormalities in Cisplatin-induced Neuropathy

  2015cites this paper
• Evaluation of multi-neuroprotective effects of erythropoietin using cisplatin induced peripheral neurotoxicity model.

  2015cites this paper
• Membrane lipid therapy: Modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment.

  2015cites this paper
• The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa

  2014cites this paper
• Plasma membranes as heat stress sensors: from lipid-controlled molecular switches to therapeutic applications.

  2014cites this paper
• Hydroximic acid derivatives: pleiotropic HSP co-inducers restoring homeostasis and robustness.

  2013cites this paper
• Effect of synthetic eel calcitonin, elcatonin, on cold and mechanical allodynia induced by oxaliplatin and paclitaxel in rats.

  2012cites this paper
• BGP-15, a PARP-inhibitor, prevents imatinib-induced cardiotoxicity by activating Akt and suppressing JNK and p38 MAP kinases

  2012cites this paper
• Altered phosphorylation of mitogen-activated protein kinases in dorsal root ganglia and sciatic nerve of rats with cisplatin-induced neuropathy

  2012cites this paper
• In Vivo Models and Assessment of Pharmacotherapeutics for Chemotherapy-Induced Neuropathic Pain

  2012cites this paper
• Chemotherapy-Induced Neuropathic Pain

  2012cites this paper
• Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy

  2012cites this paper
• Novel Therapeutic Targets in Soft Tissue Sarcomas

  2011cites this paper
• Animal models of neuropathic pain

  2011cites this paper
• BGP-15 inhibits caspase-independent programmed cell death in acetaminophen-induced liver injury.

  2010cites this paper
• Prevention of Paclitaxel-induced allodynia by Minocycline: Effect on loss of peripheral nerve fibers and infiltration of macrophages in rats

  2010cites this paper
• Enhancement of Anticancer Activities of Ephedra sinica Stapf Extracts by Nano-encapsulation

  2010cites this paper
• Influence of dosing schedules on toxicity and antitumour effects of combined cisplatin and docetaxel treatment in mice

  2009cites this paper
• Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy.

  2009cites this paper
• Sex-related differences in cisplatin-induced neuropathy in rats.

  2009cites this paper
• Evaluation Tools and Animal Models of Peripheral Neuropathies

  2008cites this paper
• Paclitaxel-Induced Peripheral Neuropathy Using NCI-CTC in Isfahan, Iran

  2008cites this paper
• Peripheral Neuropathy Due to Chemotherapy and Radiation Therapy

  2006cites this paper
• The role of growth factors in the prevention and treatment of chemotherapy-induced peripheral neurotoxicity.

  2006cites this paper
• New coordination modes of substituted benzohydroxamic acid with dialkyltin(IV) : Structural diversity through ligand isomerization

  2006cites this paper
• Changes in tracheo-bronchial sensory neuropeptide receptor gene expression pattern in rats with cisplatin-induced sensory neuropathy.

  2006cites this paper
• Decreased sensory neuropeptide release in isolated bronchi of rats with cisplatin-induced neuropathy.

  2005cites this paper
• Chemopotentiation by PARP inhibitors in cancer therapy.

  2005cites this paper
• Ethosuximide reverses paclitaxel‐ and vincristine‐induced painful peripheral neuropathy

  2004cites this paper
• Models of chemotherapy drug-induced peripheral neuropathy

  2004cites this paper
• Effect of chronic vincristine treatment on mechanical withdrawal response and pre-pulse inhibition in the rat.

  2004cites this paper